Objective: to explore the clinical value and effect of antiviral western medicine in patients with chronic hepatitis B. Methods: a retrospective study was conducted on 128 patients with chronic hepatitis B treated in ...Objective: to explore the clinical value and effect of antiviral western medicine in patients with chronic hepatitis B. Methods: a retrospective study was conducted on 128 patients with chronic hepatitis B treated in the infection department of our hospital from April 2020 to January 2021. 64 patients in the observation group were treated with antiviral western medicine and 64 patients in the control group were treated with liver protecting drugs. The effects of the two groups were compared. Results: the negative conversion rate of hepatitis B virus in the observation group was higher than that in the control group at 6, 12 and 24 weeks after treatment (P < 0.05);The negative conversion rate of hepatitis B surface antigen (HBsAg) was higher than that of the control group (P < 0.05). Conclusion: antiviral western medicine has a good effect in the treatment of chronic hepatitis B. It can effectively improve the negative conversion rate of HBsAg virus and hepatitis B virus, but it also has some limitations. Therefore, on the one hand, we should take the treatment of antiviral western medicine as the first choice for the clinical treatment of chronic hepatitis B, on the other hand, we should make a targeted analysis of the patient's condition to ensure that the treatment scheme is scientific and effective.展开更多
文摘Objective: to explore the clinical value and effect of antiviral western medicine in patients with chronic hepatitis B. Methods: a retrospective study was conducted on 128 patients with chronic hepatitis B treated in the infection department of our hospital from April 2020 to January 2021. 64 patients in the observation group were treated with antiviral western medicine and 64 patients in the control group were treated with liver protecting drugs. The effects of the two groups were compared. Results: the negative conversion rate of hepatitis B virus in the observation group was higher than that in the control group at 6, 12 and 24 weeks after treatment (P < 0.05);The negative conversion rate of hepatitis B surface antigen (HBsAg) was higher than that of the control group (P < 0.05). Conclusion: antiviral western medicine has a good effect in the treatment of chronic hepatitis B. It can effectively improve the negative conversion rate of HBsAg virus and hepatitis B virus, but it also has some limitations. Therefore, on the one hand, we should take the treatment of antiviral western medicine as the first choice for the clinical treatment of chronic hepatitis B, on the other hand, we should make a targeted analysis of the patient's condition to ensure that the treatment scheme is scientific and effective.
